Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

AstraZeneca (Canada) | Researchclopedia

Back to institutions

AstraZeneca (Canada)

Mississauga, Ontariocompany

956

Works

161,600

Citations

198

h-index

Top Research Topics

Lung Cancer Treatments and Mutations Asthma and respiratory diseases Neuropeptides and Animal Physiology

Top Researchers

Peter J. Barnes University of Virginia

2,769 works222,652 citationsh-index: 216

Recent Research

Final phase 2 study results of acalabrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia

Richard R. Furman,William G. Wierda,et al.

20260 citations

Pain Mechanisms and Treatments

Lung Cancer Diagnosis and Treatment

Chronic Lymphocytic Leukemia Research

Chronic Obstructive Pulmonary Disease (COPD) Research

Health Systems, Economic Evaluations, Quality of Life

Receptor Mechanisms and Signaling

Lung Cancer Research Studies

Gastroesophageal reflux and treatments

Advanced Breast Cancer Therapies

Holger J. Schünemann Humanitas University

1,165 works202,784 citationsh-index: 174

Kenneth C. Anderson Boston University

3,074 works167,484 citationsh-index: 199

Désirée van der Heijde Leiden University Medical Center

1,347 works117,679 citationsh-index: 158

Robert A. Kyle Mayo Clinic

1,898 works117,164 citationsh-index: 164

Giuseppe Viale European School of Oncology

1,261 works112,802 citationsh-index: 157

281eTiP Lung cancer canvas: A global, real-world (RW) observational study assessing treatment patterns and outcomes in patients with early-stage non-small cell lung cancer (NSCLC)

G. Mountzios,R.A. Soo,et al.

20260 citations

24P A global physician based survey on biomarker testing in advanced NSCLC and treatment selection following MET-driven progression on 1L EGFR TKIs

L. Bonanno,D. Simmons,et al.

20260 citations

LBA1 Ceralasertib (C) + durvalumab (D) in patients (pts) with locally advanced (LA) or metastatic (m) NSCLC who progressed on or after anti-PD-(L)1 and platinum-based chemotherapy (CT): Results from LATIFY

B. Besse,E. Felip,et al.

20260 citations

Treatment Patterns and Clinical Outcomes in Metastatic HR+/HER2− and Triple-Negative Breast Cancer in Canada: The HER2− TRENDS Study

Karen Gambaro,Kahina Rachedi,et al.

20260 citations

Real-World Evidence in Action: A Comprehensive Environmental Scan of Real-World Evidence Use in Health Technology Assessments Submitted to Canada’s Drug Agency From 2020 to 2024

Ghayath Janoudi,Russanthy Velummailum,et al.

20260 citations